Liraglutide user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or where they got the medicine, and no figure on it is a recommendation. The dose is for the doctor to decide: Liraglutide dosage.

In short

Of 188 people, 127 (68%) said liraglutide brought some benefit and 123 (65%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/liraglutide (205 accounts) and r/Ozempic (1), 17 Oct 2024 to 1 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about liraglutide, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 27/30 (90%).

Whose accounts these are: routes mentioned: injection 130; the others did not say. The figures describe the writers and are not a recommendation. We do not know whether the writers’ medicine came from a pharmacy or from elsewhere.

Did liraglutide help? The overall picture

Of 188 people, 56 (30%) reported benefit only, 71 (38%) both benefit and harm, 52 (28%) harm only and 9 (5%) neither.

Stopping. 22 people (12%) said they stopped or paused: 11 because of harms and 11 because they noticed no effect or for another reason.

Share = people / 188.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only5630%
Both benefit and harm7138%
Harm only5228%
Neither benefit nor harm95%

Most common reported benefits

Of 188 people. 127 (68%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Weight loss8746%
Less appetite and food noise6836%
More energy42%
Better mood32%
Less urge to drink21%
Better blood sugar or HbA1c21%
Better sleep or sleep apnoea11%
Other benefit63%

Share = people / 188.

Most common reported harms

Of 188 people. 123 (65%) mentioned some harm; 6 said explicitly they had none.

ReportedPeopleShare
Nausea3318%
Constipation179%
Stomach pain or bloating169%
Food aversion or eating too little158%
Fatigue158%
Vomiting158%
Diarrhoea137%
Burping105%
Injection site reaction95%
Headache84%
Mood or anxiety84%
Insomnia or sleep problems74%
Dizziness63%
Heartburn or reflux53%
Rash or itch42%
Hair loss32%
Raised heart rate or palpitations32%
Allergic reaction, hives or rash21%
Dehydration11%
Loose skin or facial change11%
Low blood sugar11%
Other, rarer harm2212%
Harms mentioned but not named158%

Share = people / 188.

How severe were the harms?

Of the 122 people who described how strong a harm was, 56 (46%) described it as mild, 60 (49%) as clearly bothersome and 6 (5%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 122.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable5646%
Clearly bothersome: several days, sleep or work affected6049%
Severe: emergency visit, hospital or unable to function65%

Harms known from research and regulators: What side effects does liraglutide have?

How long did people use liraglutide?

147 of 188 people (78%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 147.
Stated length of usePeopleShare
Under a week2416%
1-4 weeks4430%
1-3 months5135%
Over 3 months2819%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

16 of 188 people (9%) mentioned using other medicines or products at the same time. We do not name them on this page.

A prescription medicine: what this page does not tell

Liraglutide is a prescription medicine; whether to use it and at what dose is for the doctor to decide. We did not record doses, dose changes, where the medicine came from or how much weight was lost, and we do not name the other medicines people used at the same time. Side effects seen in trials: What side effects does liraglutide have?

The weight-loss drug side-effects guide has its own section on the side effects users report: what users themselves report about side effects. Its side-effect shares are higher than on this page because its posts were chosen for side-effect wording, while this page's posts are drawn from all posts about the medicine.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. The dose is for the doctor to decide. Approved doses and trial doses, with sources: Liraglutide dosage in studies. Legal status: Is liraglutide legal in Finland?

What can be concluded?

Weight loss and less appetite were the most common reported benefits, but harms were reported more often than in this site's semaglutide and tirzepatide summaries. The accounts do not replace a doctor's assessment.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, people tend to post when something goes wrong, and the accounts cannot separate the effect of the medicine from other causes. The research and its evidence levels: Liraglutide: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Retatrutide user experiences, Cagrilintide user experiences, Semaglutide user experiences, Tirzepatide user experiences, NAD+ user experiences, MOTS-c user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.